Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer
Douglas Yee(University of Minnesota Medical Center), Minetta C. Liu(Mayo Clinic), Angela DeMichele(University of Pennsylvania), Andres Forero‐Torres(Kirklin Clinic), Erin D. Ellis(University of Hawaii Cancer Center), Idris Tolgay Ocal(Mayo Clinic in Arizona), Lajos Pusztai(Yale University), Qamar J. Khan(University of Kansas Medical Center), Janice Lu(University of Southern California), Judy C. Boughey(Mayo Clinic in Arizona), Husain Sattar(University of Chicago), Kathi Adamson, Julie E. Lang(University of Southern California), Erica Stringer-Reasor(University of Alabama at Birmingham), Brian Datnow(University of California, San Diego), Oluwole Fadare(University of California, San Diego), Mara H. Rendi(University of Washington), David Euhus(The University of Texas Southwestern Medical Center), Sunati Sahoo(The University of Texas Southwestern Medical Center), Mike Feldman(University of Pennsylvania), Kirsten K. Edmiston(Virginia Cancer Institute), Donald W. Northfelt(Mayo Clinic in Arizona), A. Jo Chien(University of California, San Francisco), Shuko Harada(University of Alabama at Birmingham), Gregor Krings(University of California, San Francisco), Hyo S. Han(Moffitt Cancer Center), Kathy S. Albain(Loyola University Chicago), Sharon B. Sams(University of Colorado Denver), Ossama Tawfik(University Medical Center), Christina Yau(Hospital Authority), Shi Wei(University of Alabama at Birmingham), Amy S. Clark(Abramson Center for Jewish Life), Rebecca K. Viscusi(University of Arizona), Kathleen Kemmer(University of Michigan), Claudine Isaacs(Georgetown University), Beiyun Chen(Mayo Clinic), Jay Zeck(Georgetown University), John W. Park(University of California, San Francisco), Anthony M. Magliocco(Cancer Prevention Institute of California), Paulette Mhawech‐Fauceglia, Lauren LeBeau(University of Arizona), Stefan E. Pambuccian(Loyola University Chicago), Anne M. Wallace(University of California San Diego), Jane Yuet Ching Hui, Anthony Elias(University of Colorado Cancer Center), Molly Klein(University of Minnesota), Tuyethoa N. Vinh(Inova Health System), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center), Yunn-Yi Chen(University of California, San Francisco), Rita Nanda(University of Chicago)
Cited by 225
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
|Journal of Clinical Oncology|2007|1.6k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k